Clinical Trials in New Hampshire
Here are the 6 most popular medical studies in New Hampshire Clinical Trials
Pragmatic for Inflammatory Bowel Disease (IBD)
Recruiting1 award22 criteria
Lebanon, New Hampshire
This trial will compare the effectiveness of switching to a different immunomodulator drug versus continuing the same drug in patients with IBD who are in remission but have moderate to severe endoscopic inflammation.
PD-1 Inhibitor
Pembrolizumab + Azacitidine + Venetoclax for Acute Myeloid Leukemia
Recruiting1 awardPhase 2
Lebanon, New Hampshire
This trial is testing a new combination of drugs to treat acute myeloid leukemia in older patients. The drugs work in different ways to stop the growth of cancer cells. The trial may help the body's immune system attack the cancer and reduce the chance of the leukemia coming back.
Popular filter options for New Hampshire Clinical Trials trials
Phase 3 Clinical Trials
View 100 phase 3 medical studies.
Immunostimulant
Combination Immunotherapy for Lung Cancer
Recruiting1 awardPhase 2 & 3
West Haven, Connecticut
This trial is testing immunotherapy treatment with N-803 and pembrolizumab for advanced non-small cell lung cancer. N-803 may activate natural killer cells so that they can stimulate an immune response to help fight cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread.
Clinical Trials With No Placebo
View 100 medical studies that do not have a placebo group.
Sphingosine 1-phosphate receptor modulator
Etrasimod for Ulcerative Colitis
Recruiting1 awardPhase 2
Boston, Massachusetts
This trial will test the safety and effectiveness of a new drug, etrasimod, for treating ulcerative colitis in adolescents. If it is successful, participants will be able to take the drug for up to 5 years.
View More New Hampshire Clinical Trials Trials
See another 85 many medical studies focused on New Hampshire Clinical Trials.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.